10/26, 10:19 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Pfizer Inc

FDA panel recommends Pfizer's low-dose vaccine for kids under 12

A United States Food and Drug Administration (FDA) panel recommended on Tuesday the use of a lower dose Pfizer/BioNTech coronavirus vaccine for children aged between five and eleven.

The recommendation came from the agency's Vaccines and Related Biological Products Advisory Committee and is expected to be confirmed as a final decision by the FDA over the next few days.

Earlier, media reports said the FDA found that the benefits of the use of the jab on kids outweigh the risks and that the vaccine is highly effective in preventing symptomatic infections.

Breaking the News / NP